Links to other pages within Patient UK which are related to this topic:
Experience | Support | News | Products | Other
Print options:   Other options:   Bookmark and Share

This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Neuroblastomas

Post your experience
See others (4 there)
Description
  • Neuroblastoma is an embryonal neoplasm and is predominantly a disease of early childhood.1
  • Other than brain tumours it is the most common solid tumour of childhood and is currently responsible for the highest number of disease related deaths in pre-school age children.2
  • The neuroblastoma originates from sympathetic nervous tissue most commonly in the adrenal or paraspinal sites.
  • Metastases are present in approximately 60% at the time of diagnosis.
Epidemiology
  • Less than 100 children are diagnosed with neuroblastoma each year in the UK.
  • 90% of those diagnosed are under the age of 5 with a peak age of incidence of 2-3.3
  • The aetiology is unknown, but is thought that some may have a genetic predisposition with chromosome 1 or chromosome 16 being the most likely source.4
  • 60% of cases present in children under the age of five and it is even occasionally diagnosed pre-natally on ultrasound scan.5
Presentation6

Presentation is usually quite late and the majority of symptoms and signs occur either due to the mass effect of the tumour or as a result of metastases.

Symptoms

  • Loss of appetite
  • Occasionally watery diarrhoea due to vaso-active intestinal polypeptide (VIP)secretion
  • Vomiting
  • Weight loss
  • Fatigue
  • Bruising due to pancytopenia as a result of marrow infiltration
  • Periorbital bruising - "racoon eyes" (due to metastatic disease in the orbits)
  • Weakness, limping, paralysis and bladder and bowel dysfunction due to spinal cord compression from paraspinal sympathetic tumours
  • Bone pain (due to bone metastases)
  • Cerebellar ataxia and myoclonus - rare
  • Permanent cognitive deficits - rare

Signs

  • Mild fever
  • Abdominal distension due to enlarged liver
  • Hypertension - due to pressure on the renal artery
  • Horner's syndrome due to thoracic lesion
  • Primary cervical neuroblastoma is rare but may result in a mass in the neck
  • "Blueberry muffin baby" - occurs in neonates, metastases cause severe skin involvement, results in a characteristic appearance
Differential diagnosis6

The differential diagnosis includes other tumours of early childhood such as :

Depending on presentation, other conditions that may need to be considered include:

  • Osteomyelitis
  • Rheumatoid arthritis
  • Disseminated bone disease
  • Primary neurologic disease
  • Inflammatory bowel disease
Investigations7

Laboratory tests

  • Full blood count - this may detect anaemia.
  • ESR may be raised.
  • Coagulation tests -
    • Prothrombin time and partial thromboplastin time may be abnormal once liver involvement occurs.
    • Thrombocytopaenia may occur when once deposits overwhelm the bone marrow.
    • Catecholamine by-products can be detected in the urine of patients with neuroblastoma. These include:
      • Homovanillic acid (HVA) and vanillylmandelic acid (VMA). A low VMA-to-HVA ratio is consistent with a poorly differentiated tumour and indicative of a poor prognosis.
      • Neuron-specific enolase (NSE) - elevated levels can be demonstrated in 96% of patients with metastases, indicating a poor prognosis.

Radio-imaging

  • Plain abdominal X-ray may be a useful initial screening test for any child with an abdominal mass.
  • Ultrasound will help to further assess the site and size of any intra-abdominal tumour and any abnormalities of the urogenital tract. Small flecks of calcification may be seen in the abdomen or posterior mediastinum.
  • MRI8 and CT scanning may add further information regarding is the site of primary or secondary tumours.
  • Bone scan may be used to assess secondary lesions. A compound called metaiodobenzylguanidine (MIBG) is taken up specifically by catecholaminergic cells and can help to detect metastatic disease in bones as well as soft tissue. If this is negative but metastases are clinically suspected, technetium bone scan may be helpful.

Procedures

Biopsy of the lesion or of deposits in bone marrow are necessary in order to make a definitive diagnosis.

For an unequivocal diagnosis the following must apply:

  • Light microscopy of tumour biopsy samples, with or without electron microscopy plus increased catecholamine levels or immunohistology.
  • Identification of tumour cells from bone marrow aspirate and increased levels of serum or urinary catecholamines.
Staging

The International Neuroblastoma Staging System (INSS) was developed as a prognostic and research tool. Localised tumours were divided into stages 1,2 and 3 according to regional lymph node involvement and whether the tumour infiltrates across the midline or is resectable. All patients over the age of 1 with distant involvement were categorised as stage 4.6

More recently, an attempt has been made to introduce some international uniformity. This is important both to compare treatment strategies and because modern treatment is very much tailored to the risk classification of individual patients. The result has been the development of the International Risk Group Staging System (INRGSS). Clinical and biological factors were combined to define low, intermediate, high (4 groups) or ultra-high-risk.9

Management

Non-drug

Families with an affected child will need long term support and may benefit from referral to specialist nurses e.g. Macmillan nurses.

Drug7

  • Plasmapheresis and intravenous gammaglobulin may be useful, especially in some cases with eye involvement (opisclonus/myoclonus syndrome).10,11
  • Chemotherapy is used in inoperable cases or as an adjunct to surgery or radiotherapy. Various combinations of agents have been tried, of which the commonest are carboplatin, cyclophosphamide, doxorubicin and etoposide. The duration of treatment can vary from 6 to 24 weeks. More severe cases (25-30% survival) may also be treated with high dose cisplatin and ifosfamide in addition to this regime.
  • Adrenocortical hormone (ACTH) is sometimes useful in controlling symptoms and has even been implicated in some cases of 'spontaneous' remission.12
  • Other therapies currently being investigated include biological response modifiers, anti-angiogenesis agents which inhibit blood vessel growth in the more vascular neuroblastomas and targeted immunotherapy.

Surgery7

  • Surgical removal of the tumour alone may be used in some low risk tumours (90% survival), but more commonly surgery is combined with chemotherapy.
  • An initial laparotomy is usually performed, to determine an accurate diagnosis, remove all of the primary tumor and provide accurate staging.
  • Intra-operative radiotherapy has been found to improve survival rates and causes less adverse effects than external beam radiotherapy.13
  • A further operation is often performed to remove residual disease.

Modern management is tailored to the risk stratification of individual patients. In basic terms:

  • Low risk patients are simply observed for spontaneous resolution or are treated with local resection.
  • Intermediate risk patients may be offered multimodal therapy including surgery, chemotherapy and radiation therapy.
  • High-risk patients are given multiagent chemotherapy, surgery and radiotherapy, followed by consolidation with high-dose chemotherapy and peripheral blood stem cell rescue. The addition of 13-cis-retinoic acid (isotretinoin) is sometimes beneficial in these patients.14
Complications

Complications at presentation

  • Cord compression from paraspinal tumour
  • Severe hypertension
  • Renal insufficiency

Complications during or after chemotherapy

Surgical complications

Prognosis7
  • The prognosis varies with the age of the patient, the site of the primary, the stage of the disease, lymph node involvement and the tumour histology.
  • Children of any age with localised disease and children under the age of 1 at presentation with advanced disease tend to respond well to treatment and may have prolonged disease free periods. Older children with advanced disease may have a 2 year survival rate of 20% despite aggressive chemotherapy.
  • Neuroblastoma in adolescence or adulthood has a more prolonged course, 50 % achieving a minimal disease state with aggressive chemotherapy, but the long term prognosis remains poor. A few lesions will spontaneously regress or mature into benign lesions.
  • It is hoped that further work on the histopathological types of neuroblastoma, the genetic factors and governing tumour growth and the biological markers produced by such genetic aberration will help to refine the determination of prognosis in individual patients.16,17

Document references
  1. Kushner BH; Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med. 2004 Jul;45(7):1172-88. [abstract]
  2. Grovas A, Fremgen A, Rauck A, et al; The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer. 1997 Dec 15;80(12):2321-32. [abstract]
  3. Macmillan Cancer Support (Cancerbackup); Neuroblastoma n children.
  4. Maris JM, Weiss MJ, Mosse Y, et al; Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. Cancer Res. 2002 Nov 15;62(22):6651-8. [abstract]
  5. Penn State Children's Hospital; Neuroblastoma
  6. Lacayo N, Neyssa M; Neuroblastoma. eMedicine, 2007.
  7. Joyner B; Neuroblastoma. eMedicine, 2006.
  8. Siegel MJ, Jaju A; MR imaging of neuroblastic masses. Magn Reson Imaging Clin N Am. 2008 Aug;16(3):499-513, vi. [abstract]
  9. Cohn S, London W, Monclair T et al; Update on the development of the international neuroblastoma risk group (INRG) classification schema. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 9503
  10. Mitchell WG, Davalos-Gonzalez Y, Brumm VL, et al; Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics. 2002 Jan;109(1):86-98. [abstract]
  11. Russo C, Cohn SL, Petruzzi MJ, et al; Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol. 1997 Apr;28(4):284-8. [abstract]
  12. Tucker GR; Adrenocorticotropic hormone in the aetiology and regression of neuroblastoma. Med Hypotheses. 2002 Aug;59(2):117-28. [abstract]
  13. Gillis AM, Sutton E, Dewitt KD, et al; Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):858-64. Epub 2007 May 22. [abstract]
  14. Matthay KK, Villablanca JG, Seeger RC, et al; Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999 Oct 14;341(16):1165-73. [abstract]
  15. Ikeda A, Sakamoto K; Tumor Lysis Syndrome. eMedicine, 2008.
  16. Shimada H, Stram DO, Chatten J, et al; Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst. 1995 Oct 4;87(19):1470-6. [abstract]
  17. Abe M, Westermann F, Nakagawara A, et al; Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas. Cancer Lett. 2006 Jun 4. [abstract]
Acknowledgements EMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.
DocID: 1711
Document Version: 21
DocRef: bgp525
Last Updated: 14 Nov 2008
Review Date: 14 Nov 2010

The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest. Find out more about updating.

Patient UK Hearing Impairment Survey

Patient UK are grateful to the 550 people who took part in this survey.
To see the results click here.
If you'd like to leave your feedback, please go to our interactive forum.

Links to other pages within Patient UK which are related to this topic:
Experience | Support | News | Products | Other
Print options:   Other options:   Bookmark and Share
Want to search some more? Use the Google Search box below to search our site.

Advertisements











Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>

Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Click here to return to the home page
Click here to read our 'About Us' page
Go to the Emis Access website, where you can book an appointment with your GP, order a repeat prescription or view you medical record online.
Note: this will open in a new window
View and/or join in discussion about health, lifestyle and disease in our interactive forum.
Note: this will open in a new window
Visit our pharmacy product price comparison website
Go to our online newspaper for current medical news and commentary.
Note: this will open in a new window
Adverts on this site do not influence the medical content. Click to read more.
Adverts on this site do not influence the medical content. Click to read more.